Greg Sargen Bio

Greg Sargen is an operating partner at Altaris and chair of the audit committee at Kindeva Drug Delivery and Veranova. Greg has over 25 years of experience in the pharmaceutical services industry and has served on the board of two publicly traded biopharmaceutical companies. Previously, Greg was Executive Vice President and Chief Financial Officer, and Vice President of Corporate Development and Strategy at Cambrex Corporation, a publicly traded Contract Development and Manufacturing Organization. Greg also held finance roles at Fisher Scientific International (now ThermoFisher), Merck & Co and Expanets. Greg began his career in auditing at Deloitte & Touche, LLP, and is a Certified Public Accountant. Greg holds a B.S. in Accounting from Penn State University and an MBA from The Wharton School.